Personalized treatment of RET-altered thyroid cancers

16/03/2022 42 min Episodio 68
Personalized treatment of RET-altered thyroid cancers

Listen "Personalized treatment of RET-altered thyroid cancers"

Episode Synopsis

touchEXPERT OPINIONS for touchENDOCRINOLOGY
Listen to leading experts explain the value of biomarker testing and targeted therapies for the personalized treatment of RET-altered thyroid cancers
The experts
Prof. Maria Cabanillas - University of Texas MD Anderson Cancer Center, Houston, TX, USA
Dr Vivek Subbiah - University of Texas MD Anderson Cancer Center, Houston, TX, USA
Dr Lori Wirth - Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, MA, USA

This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Blueprint Medicines and Genentech, a member of the Roche Group. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchendocrinologyime.org/personalized-treatment-of-ret-altered-thyroid-cancers-what-is-the-value-of-biomarker-testing-and-targeted-therapies//?_ga=2.65262702.1175448380.1654530922-407959475.1653925964

More episodes of the podcast touchPODCAST